Review
Prevention of early episodes of otitis media by pneumococcal vaccines might reduce progression to complex disease

https://doi.org/10.1016/S1473-3099(15)00549-6Get rights and content

Summary

Otitis media is a common childhood infection of the middle ear and a major cause of morbidity. This multifactorial disease manifests as a spectrum of clinical syndromes from uncomplicated acute otitis media to more complex recurrent and chronic cases (frequently polymicrobial), with the major pathogens involved being Streptococcus pneumoniae and non-typeable Haemophilus influenzae. Pneumococcal conjugate vaccines (PCVs) target only a few serotypes that cause otitis media; however, results from studies suggest that existing PCVs can prevent early episodes of disease associated with vaccine serotypes, resulting in a reduction of subsequent complex cases caused by non-vaccine serotypes and other otopathogens, which contribute considerably to the disease burden. In this Review, we discuss the role of pneumococcus in the disease continuum and assess clinical evidence showing the effect of prevention of early episodes on the complex interplay between bacterial species implicated in otitis media.

Introduction

Otitis media is a common multifactorial, polymicrobial disease of the middle ear cavity of children, ranging from uncomplicated, often asymptomatic cases to protracted manifestations, including recurrent, non-responsive, and spontaneously draining infection, and chronic disease with effusion. The most frequently involved bacterial pathogens are Streptococcus pneumoniae, non-typeable Haemophilus influenzae (NTHi), and, to a lesser extent, Moraxella catarrhalis and Streptococcus pyogenes.1, 2, 3, 4 Among children, otitis media is a leading cause of clinic visits, antibiotic prescriptions, and surgical procedures.5, 6, 7 Before the introduction of pneumococcal conjugate vaccines (PCVs), peak incidence was age 6–11 months; by age 3 years, up to 85% of children will have had one or more episodes, of whom up to 20% had recurrent infections (ie, three or more episodes) by age 1 year and up to 40% will have six or more episodes during their lifetime.5 Most acute cases in children resolve spontaneously,8 and recovery depends on factors such as age and disease severity. The two main strategies for initial management are watchful waiting (ie, wait for spontaneous resolution) or immediate antibiotic treatment,9 although data for the long-term benefits of antibiotic use are limited.10

Regardless of treatment strategy, recurrent otitis media can result in permanent sequelae and complications, including hearing impairment, speech delay, and, in rare cases, intracranial and extracranial complications.11 Recurrent, non-responsive, and spontaneously draining otitis media and their sequelae, chronic otitis media with effusion (which we collectively name in this Review as complex otitis media), can be costly. In the USA, estimated national medical expenditures for otitis media and related illness reached US$2·8 billion in 2006.12 Worldwide, chronic secretory otitis media occurs in 65 million to 330 million people each year, 50% of whom develop temporary or prolonged hearing loss.13 Thus, effective preventive measures are of paramount importance.

Since PCVs target a limited number of serotypes, their efficacy against all-cause otitis media episodes is modest, and the reduction in incidence was not significant in most pre-licensure studies;14 however, in longer-term studies they have shown specific effects on the burden of complex otitis media.2, 15, 16 Although S pneumoniae is not the most common pathogen recovered in complex disease,17, 18, 19, 20 results from early clinical trials showed that prevention of pneumococcal otitis media by PCVs was linked to reduction in recurrent and chronic infection with effusion in long-term follow-ups.21, 22, 23, 24, 25 Subsequently, in several studies done after widespread implementation of vaccination programmes, substantial reductions were reported in recurrent infections, ventilation tube insertion, otitis media-related antibiotic use, and medical service use.16, 26, 27, 28, 29

We hypothesise that widespread use of PCVs led to reductions in early acute otitis media episodes caused by vaccine-type S pneumoniae, which in turn abrogated the subsequent pathogenic process that leads to complex otitis media, reducing the disease burden beyond that directly caused by vaccine-type serotypes. In this Review, we describe the complexity of sequential otitis media infections and, on the basis of clinical evidence, discuss how PCVs potentially reduce progression to complex otitis media (often caused by non-vaccine-type S pneumoniae and pathogens other than S pneumoniae) by preventing early episodes of otitis media.

Section snippets

Microbial complexity: associated bacterial pathogens

The cause of otitis media is multifactorial and often polymicrobial. Its pathogenesis and clinical presentation depend on anatomical and physiological variations in patients, environmental factors, and associated pathogens.4, 30 Pathogen-specific factors and their interaction with the host determine disease presentation, severity, and persistence. Viruses certainly have an important role in the pathogenesis and cause of this disease,4, 31 but this discussion is beyond the scope of our Review.

Clinical presentation: the disease continuum hypothesis

Although direct evidence might be incomplete, available data for a proportion of patients suggest that the complex interplay between pathogens results in a disease continuum from early acute otitis media infection enriched with S pneumoniae2, 17, 50, 51 to a subsequent polymicrobial, complex, and persistent disease (figure 1). Pathogenesis and disease presentation vary depending on the causative agents. As shown by Palmu and colleagues (figure 2),51 acute spontaneous perforations (which suggest

Prevention: vaccination against S pneumoniae can modify the otitis media continuum

Nasopharyngeal bacterial colonisation patterns are associated with otitis media risk and presentation. Early S pneumoniae colonisation is associated with increased colonisation of additional bacterial species, including NTHi, and an elevated frequency of parent-reported respiratory tract infections.108 This finding suggests that an initial infection with invasive pneumococcal strains can predispose children to more complex forms of otitis media. Importantly, the composition of microbiota

Conclusion

S pneumoniae and NTHi are responsible for most cases of otitis media worldwide, although their contribution to the disease continuum varies. S pneumoniae is more frequently responsible for early episodes of otitis media and potentially initiates middle-ear damage, leading to a disease cascade that results in subsequent polymicrobial infections, which are generally associated with NTHi and biofilms (figure 6A). The ability of these associated otopathogens to form biofilms is key to the

Search strategy and selection criteria

We searched PubMed from Jan 1, 2000, to Dec 1, 2015, using the terms “otitis media and vaccines and bacteria” and “otitis media and biofilms”, and selected the most recent relevant articles. Only articles in English were reviewed. Relevant references included in these publications were also used. We added additional references from our personal files as needed.

References (141)

  • G Karevold et al.

    Surgery for otitis media and infectious susceptibility in 10-year old school children

    Int J Pediatr Otorhinolaryngol

    (2009)
  • CL Kuo et al.

    Otitis media with effusion in children with cleft lip and palate: a narrative review

    Int J Pediatr Otorhinolaryngol

    (2013)
  • NL Shapiro et al.

    Otitis media in children with vertically-acquired HIV infection: the Great Ormond Street Hospital experience

    Int J Pediatr Otorhinolaryngol

    (1998)
  • CD Bluestone

    Epidemiology and pathogenesis of chronic suppurative otitis media: implications for prevention and treatment

    Int J Pediatr Otorhinolaryngol

    (1998)
  • F Pumarola et al.

    Microbiology of bacteria causing recurrent acute otitis media (AOM) and AOM treatment failure in young children in Spain: shifting pathogens in the post-pneumococcal conjugate vaccination era

    Int J Pediatr Otorhinolaryngol

    (2013)
  • R Commisso et al.

    Acute otitis media: bacteriology and bacterial resistance in 205 pediatric patients

    Int J Pediatr Otorhinolaryngol

    (2000)
  • PS Stewart et al.

    Antibiotic resistance of bacteria in biofilms

    Lancet

    (2001)
  • G Zuliani et al.

    Identification of adenoid biofilms in chronic rhinosinusitis

    Int J Pediatr Otorhinolaryngol

    (2006)
  • E Leibovitz et al.

    Acute otitis media in children: current epidemiology, microbiology, clinical manifestations, and treatment

    Chang Gung Med J

    (2004)
  • R Dagan et al.

    Mixed pneumococcal-nontypeable Haemophilus influenzae otitis media is a distinct clinical entity with unique epidemiologic characteristics and pneumococcal serotype distribution

    J Infect Dis

    (2013)
  • RC Holder et al.

    One third of middle ear effusions from children undergoing tympanostomy tube placement had multiple bacterial pathogens

    BMC Pediatr

    (2012)
  • HM Massa et al.

    Otitis media: viruses, bacteria, biofilms and vaccines

    Med J Aust

    (2009)
  • AS Lieberthal et al.

    The diagnosis and management of acute otitis media

    Pediatrics

    (2013)
  • RP Venekamp et al.

    Antibiotics for acute otitis media in children

    Cochrane Database Syst Rev

    (2013)
  • I Brook

    Watchful waiting versus immediate antibiotic treatment in the management of acute otitis media in children

    Curr Infect Dis Rep

    (2007)
  • A Qureishi et al.

    Update on otitis media—prevention and treatment

    Infect Drug Resist

    (2014)
  • TT Jung et al.

    Panel 8: Complications and sequelae

    Otolaryngol Head Neck Surg

    (2013)
  • A Soni

    Medical Expenditure Panel Survey (statistical brief #228): Ear infections (otitis media) in children (0–17): use and expenditures, 2006

    (2008)
  • L Monasta et al.

    Burden of disease caused by otitis media: systematic review and global estimates

    PLoS One

    (2012)
  • S Taylor et al.

    Impact of pneumococcal conjugate vaccination on otitis media: a systematic review

    Clin Infect Dis

    (2012)
  • MA Fletcher et al.

    Pneumococcal conjugate vaccines and otitis media: an appraisal of the clinical trials

    Int J Otolaryngol

    (2012)
  • G Barkai et al.

    Potential contribution by nontypable Haemophilus influenzae in protracted and recurrent acute otitis media

    Pediatr Infect Dis J

    (2009)
  • E Bingen et al.

    Epidemiologic study of conjunctivitis–otitis syndrome

    Pediatr Infect Dis J

    (2005)
  • L Caeymaex et al.

    Characteristics and outcomes of acute otitis media in children carrying Streptococcus pneumoniae or Haemophilus influenzae in their nasopharynx as a single otopathogen after introduction of the heptavalent pneumococcal conjugate vaccine

    Pediatr Infect Dis J

    (2014)
  • S Black et al.

    Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children

    Pediatr Infect Dis J

    (2000)
  • B Fireman et al.

    Impact of the pneumococcal conjugate vaccine on otitis media

    Pediatr Infect Dis J

    (2003)
  • J Eskola et al.

    Efficacy of a pneumococcal conjugate vaccine against acute otitis media

    N Engl J Med

    (2001)
  • AA Palmu et al.

    The seven-valent pneumococcal conjugate vaccine reduces tympanostomy tube placement in children

    Pediatr Infect Dis J

    (2004)
  • I Sarasoja et al.

    Long-term effect of pneumococcal conjugate vaccines on tympanostomy tube placements

    Pediatr Infect Dis J

    (2013)
  • CG Grijalva et al.

    National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States

    Pediatrics

    (2006)
  • KA Poehling et al.

    Reduction of frequent otitis media and pressure-equalizing tube insertions in children after introduction of pneumococcal conjugate vaccine

    Pediatrics

    (2007)
  • F Zhou et al.

    Trends in acute otitis media-related health care utilization by privately insured young children in the United States, 1997–2004

    Pediatrics

    (2008)
  • A Jardine et al.

    The impact of pneumococcal conjugate vaccine on rates of myringotomy with ventilation tube insertion in Australia

    Pediatr Infect Dis J

    (2009)
  • JM Coticchia et al.

    New paradigms in the pathogenesis of otitis media in children

    Front Pediatr

    (2013)
  • CD Bluestone et al.

    Ten-year review of otitis media pathogens

    Pediatr Infect Dis J

    (1992)
  • TR Coker et al.

    Diagnosis, microbial epidemiology, and antibiotic treatment of acute otitis media in children: a systematic review

    JAMA

    (2010)
  • WP Hanage

    Serotype-specific problems associated with pneumococcal conjugate vaccination

    Future Microbiol

    (2008)
  • ME Pichichero

    Evolving shifts in otitis media pathogens: relevance to a managed care organization

    Am J Manag Care

    (2005)
  • K Revai et al.

    Effect of pneumococcal conjugate vaccine on nasopharyngeal bacterial colonization during acute otitis media

    Pediatrics

    (2006)
  • WP Hanage et al.

    Diversity and antibiotic resistance among nonvaccine serotypes of Streptococcus pneumoniae carriage isolates in the post-heptavalent conjugate vaccine era

    J Infect Dis

    (2007)
  • Cited by (103)

    • Streptococcus pneumoniae as cause of acute otitis media (AOM) in Slovak children in the pneumococcal conjugate vaccine era (2008–2019)

      2023, Vaccine
      Citation Excerpt :

      Moreover the effect of parallel schedules on carriage reduction is unknown. The reduction of non-vaccine serotypes (Fig. 4) is at first puzzling; however, as first hypothesized by Dagan and colleagues [20], prevention of a first episode of pneumococcal AOM prevents damage to the middle ear, which may be the pre-requisite for later episodes of AOM caused by less common and less pathogenic, non-vaccine serotypes later in live. Even AOM associated with totally unrelated bacteria like Streptococcus pyogenes or Moraxella catarrhalis might be prevented by this indirect, non-immunological effect [21].

    View all citing articles on Scopus
    View full text